Serum 25-Hydroxyvitamin D Deficiency and the 5-Year Incidence of CKD

被引:44
作者
Damasiewicz, Matthew J. [1 ,2 ]
Magliano, Dianna J. [3 ]
Daly, Robin M. [4 ,5 ]
Gagnon, Claudia [5 ,6 ]
Lu, Zhong X. [2 ,7 ]
Sikaris, Ken A. [7 ]
Ebeling, Peter R. [5 ]
Chadban, Steven J. [8 ,9 ]
Atkins, Robert C. [3 ]
Kerr, Peter G. [1 ,2 ]
Shaw, Jonathan E. [3 ]
Polkinghorne, Kevan R. [1 ,2 ]
机构
[1] Monash Med Ctr, Dept Nephrol, Melbourne, Vic, Australia
[2] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[3] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia
[4] Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia
[5] Univ Melbourne, Western Hlth, NorthWest Acad Ctr, Melbourne, Vic, Australia
[6] Univ Laval, Ctr Rech CHUQ, Quebec City, PQ, Canada
[7] Melbourne Pathol, Melbourne, Vic, Australia
[8] Royal Prince Alfred Hosp, Dept Nephrol & Transplantat, Sydney, NSW, Australia
[9] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Vitamin D; albuminuria; chronic kidney disease; glomerular filtration rate; decreased kidney function; CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-ALDOSTERONE SYSTEM; NEGATIVE ENDOCRINE REGULATOR; VITAMIN-D LEVELS; NF-KAPPA-B; IMPROVED SURVIVAL; D SUPPLEMENTATION; LIFE-STYLE; ALBUMINURIA; OBESITY;
D O I
10.1053/j.ajkd.2013.03.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Low serum 25-hydroxyvitamin D (25[OH] D) levels have been associated with chronic kidney disease in cross-sectional studies. However, this association has not been studied prospectively in a large general population-based cohort. Study Design: Prospective cohort study. Setting & Participants: 6,180 adults 25 years or older participating in the baseline and 5-year follow-up phases of the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Predictor: Serum 25(OH) D levels <15 ng/mL were considered deficient. Outcomes & Measurements: Incident chronic kidney disease was defined as being negative at baseline but positive after 5 years for (1) reduced estimated glomerular filtration rate (eGFR; <60 mL/min/1.72 m(2)) or (2) albuminuria (spot urine albumin-creatinine ratio >= 2.5 mg/mmol [>= 22.1 mg/g] for men and >= 3.5 mg/mmol [>= 30.9 mg/g] for women). Results: 623 (10.9%) participants were vitamin D deficient, 161 developed incident reduced eGFR, and 222 developed incident albuminuria. In participants with and without vitamin D deficiency, annual age-standardized incidences were 0.92% (95% CI, 0.56%-1.30%) and 0.59% (95% CI, 0.51%-0.68%), respectively, for eGFR <60 mL/min/1.72 m(2) and 1.50% (95% CI, 1.06%-1.95%) and 0.66% (95% CI, 0.56%-0.76%), respectively, for albuminuria. In multivariate regression models, vitamin D deficiency was associated significantly with the 5-year incidence of albuminuria (OR, 1.71; 95% CI, 1.12-2.61; P = 0.01), but not reduced eGFR (OR, 0.93; 95% CI, 0.53-1.66; P = 0.8). Limitations: The observational nature of the study does not account for unmeasured confounders. Only baseline 25(OH) D level was measured and therefore may not accurately reflect lifetime levels. Differences in baseline characteristics of participants who were included compared with those excluded due to missing data or follow-up may limit the applicability of results to the original AusDiab cohort. Conclusions: Our prospective cohort study shows that vitamin D deficiency is associated with a higher annual incidence of albuminuria and reduced eGFR and independently predicts the 5-year incidence of albuminuria. These associations warrant further exploration in long-term prospective clinical trials. Am J Kidney Dis. 62(1):58-66. (C) 2013 by the National Kidney Foundation, Inc.
引用
收藏
页码:58 / 66
页数:9
相关论文
共 53 条
[1]   Update in Vitamin D [J].
Adams, John S. ;
Hewison, Martin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02) :471-478
[2]   Antiproteinuric effect of oral paricalcitol in chronic kidney disease [J].
Agarwal, R ;
Acharya, M ;
Tian, J ;
Hippensteel, RL ;
Melnick, JZ ;
Qiu, P ;
Williams, L ;
Batlle, D .
KIDNEY INTERNATIONAL, 2005, 68 (06) :2823-2828
[3]  
[Anonymous], Dietary reference intakes for calcium and vitamin D
[4]   Long-Term Follow-Up for Mortality and Cancer in a Randomized Placebo-Controlled Trial of Vitamin D3 and/or Calcium (RECORD Trial) [J].
Avenell, Alison ;
MacLennan, Graeme S. ;
Jenkinson, David J. ;
McPherson, Gladys C. ;
McDonald, Alison M. ;
Pant, Puspa R. ;
Grant, Adrian M. ;
Campbell, Marion K. ;
Anderson, Frazer H. ;
Cooper, Cyrus ;
Francis, Roger M. ;
Gillespie, William J. ;
Robinson, C. Michael ;
Torgerson, David J. ;
Wallace, W. Angus .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) :614-622
[5]   Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[6]   New Vitamin D analogs and changing therapeutic paradigms [J].
Cunningham, John ;
Zehnder, Daniel .
KIDNEY INTERNATIONAL, 2011, 79 (07) :702-707
[7]   Wnt/β-Catenin Signaling Promotes Podocyte Dysfunction and Albuminuria [J].
Dai, Chunsun ;
Stolz, Donna B. ;
Kiss, Lawrence P. ;
Monga, Satdarshan P. ;
Holzman, Lawrence B. ;
Liu, Youhua .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (09) :1997-2008
[8]   25-hydroxyvitamin D Levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study [J].
Damasiewicz, Matthew J. ;
Magliano, Dianna J. ;
Daly, Robin M. ;
Gagnon, Claudia ;
Lu, Zhong X. ;
Ebeling, Peter R. ;
Chadban, Steven J. ;
Atkins, Robert C. ;
Kerr, Peter G. ;
Shaw, Jonathan E. ;
Polkinghorne, Kevan R. .
BMC NEPHROLOGY, 2012, 13
[9]   25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III) [J].
de Boer, Ian H. ;
Ioannou, George N. ;
Kestenbaum, Bryan ;
Brunzell, John D. ;
Weiss, Noel S. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (01) :69-77
[10]   Serum 25-Hydroxyvitamin D and Change in Estimated Glomerular Filtration Rate [J].
de Boer, Ian H. ;
Katz, Ronit ;
Chonchol, Michel ;
Ix, Joachim H. ;
Sarnak, Mark J. ;
Shlipak, Michael G. ;
Siscovick, David S. ;
Kestenbaurn, Bryan .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (09) :2141-2149